Wellington Management Group LLP Has $15.20 Million Position in OrthoPediatrics Corp. $KIDS

Wellington Management Group LLP lessened its stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 10.5% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 794,309 shares of the company’s stock after selling 93,135 shares during the period. Wellington Management Group LLP owned about 3.04% of OrthoPediatrics worth $15,195,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Russell Investments Group Ltd. increased its stake in shares of OrthoPediatrics by 433.1% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock worth $26,000 after purchasing an additional 1,139 shares during the last quarter. Legal & General Group Plc acquired a new position in shares of OrthoPediatrics in the second quarter valued at $34,000. Northwestern Mutual Wealth Management Co. grew its stake in OrthoPediatrics by 5,226.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock valued at $46,000 after buying an additional 2,561 shares during the last quarter. Caption Management LLC bought a new position in shares of OrthoPediatrics during the third quarter worth approximately $54,000. Finally, BNP Paribas Financial Markets increased its position in OrthoPediatrics by 60.2% during the 3rd quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after buying an additional 1,235 shares during the period. 69.05% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms have recently weighed in on KIDS. Truist Financial set a $22.00 price target on shares of OrthoPediatrics in a research report on Wednesday, August 5th. BTIG Research raised their price target on shares of OrthoPediatrics from $24.00 to $29.00 and gave the company a “buy” rating in a research note on Thursday, August 20th. Weiss Ratings upgraded OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 5th. Piper Sandler reissued an “overweight” rating and set a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a report on Wednesday, August 5th. Finally, TD Cowen restated a “buy” rating on shares of OrthoPediatrics in a research report on Monday, June 15th. Nine equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $26.44.

OrthoPediatrics Stock Performance

Shares of KIDS opened at $22.41 on Tuesday. The company has a market cap of $585.13 million, a PE ratio of -13.34 and a beta of 0.99. OrthoPediatrics Corp. has a one year low of $14.42 and a one year high of $26.74. The stock has a 50-day moving average of $21.83 and a 200-day moving average of $18.92. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.78 and a quick ratio of 2.17.

OrthoPediatrics (NASDAQ:KIDS) last issued its earnings results on Tuesday, August 4th. The company reported ($0.26) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.30) by $0.04. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%.The company had revenue of $70.51 million for the quarter, compared to analyst estimates of $68.21 million. On average, equities research analysts predict that OrthoPediatrics Corp. will post -1.14 EPS for the current fiscal year.

Insiders Place Their Bets

In other OrthoPediatrics news, major shareholder Squadron Capital Llc sold 22,500 shares of the company’s stock in a transaction dated Wednesday, September 2nd. The shares were sold at an average price of $23.35, for a total value of $525,375.00. Following the completion of the sale, the insider directly owned 6,504,133 shares of the company’s stock, valued at approximately $151,871,505.55. This represents a 0.34% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, major shareholder Jennifer Pritzker sold 22,500 shares of the company’s stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $23.35, for a total value of $525,375.00. Following the completion of the transaction, the insider directly owned 6,504,133 shares of the company’s stock, valued at approximately $151,871,505.55. This represents a 0.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 1,192,893 shares of company stock valued at $27,689,613. Corporate insiders own 32.50% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.